Day case discharge of patients treated with drug coated balloon only angioplasty for de novo coronary artery disease: A single center experience

Ioannis Merinopoulos, Upul Wickramarachchi, James Wardley, Vikram Khanna, Tharusha Gunawardena, Clint Maart, Vassilios Vassiliou, Simon C Eccleshall

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)
14 Downloads (Pure)


Objective: To report our initial experience with Drug Coated Balloon (DCB) only angioplasty and propose a protocol to achieve this safely.
Background: There are no articles published in the literature currently regarding the safety of same day discharge in patients treated with DCB-only angioplasty.
Methods: Retrospective review of all our patients treated with DCB-only angioplasty from Sept 2017 to April 2018 with identification of potential complications relating to same day discharge.
Results: A total of 100 consecutive patients who underwent elective DCB-only angioplasty for de novo coronary artery disease and were discharged on the same day as the procedure were included. In 99% no cardiac symptoms relating to the procedure requiring urgent hospitalisation or urgent investigations were identified. One patient was readmitted the next day requiring stenting of the previously treated lesion. Our 30 day mortality was zero. Some 97 hospital bed days were saved with 100 patients treated.
Conclusion: Elective day-case DCB-only angioplasty according to our local protocol is safe and cost-effective and should be considered for the majority of the patients.
Original languageEnglish
Pages (from-to)105-108
Number of pages4
JournalCatheterization and Cardiovascular Interventions
Issue number1
Early online date7 Apr 2019
Publication statusPublished - Jan 2020


  • DCB-only angioplasty
  • day case

Cite this